Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 31, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents.

Reshu Saini1, Jason M Warram, Anna G Sorace

  • 1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.

Ultrasound in Medicine & Biology
|June 21, 2011
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor probability mapping of fluorescence intensity during image-guided surgery of head and neck cancer.

Scientific reports·2026
Same author

SAHA Alters Macrophages in the Tumor-Immune Landscape in Preclinical Models of Triple-Negative Breast Cancer.

Pharmaceutics·2026
Same author

CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.

Breast cancer research : BCR·2026
Same author

Harnessing Id1 as a biomarker in a plasmid reporter system for cervical cancer.

Scientific reports·2026
Same author

Assessment of Early Breast Cancer Response to Chemotherapy with Ultrasound Radiomics.

Diagnostics (Basel, Switzerland)·2026
Same author

Characterization of HER2-Positive Murine Breast Cancer Models for Investigating HER2-Targeted Therapy and Immunotherapy.

Cancers·2026

This study introduces a new laboratory model to test how well specialized ultrasound microbubbles attach to cancer cells. By using viral vectors to control the number of target receptors on cell surfaces, researchers created a precise way to measure binding efficiency. The results show that microbubble attachment increases directly with the density of these receptors, providing a reliable method for validating future imaging agents.

Area of Science:

  • Biomedical engineering and targeted ultrasound contrast agents research
  • Molecular imaging and oncology diagnostics

Background:

No prior work had resolved how to precisely calibrate receptor density for testing diagnostic imaging probes. Prior research has shown that molecular imaging relies heavily on the specific interaction between contrast agents and cellular markers. That uncertainty drove the development of a controlled platform to quantify these binding events. Researchers often struggle with inconsistent receptor expression levels in traditional cell culture models. This gap motivated the creation of a system using viral gene delivery to standardize target availability. It was already known that adenoviral vectors offer efficient gene transfer capabilities in various mammalian cell lines. That knowledge allowed for the systematic modulation of surface protein levels across a wide range. This study addresses the need for a standardized approach to validate the performance of targeted ultrasound microbubbles.

Purpose Of The Study:

The study aims to develop a model system for evaluating targeted ultrasound contrast agents by regulating receptor expression. Researchers sought to overcome challenges associated with inconsistent target density in traditional cell-based imaging assays. They utilized adenoviral vectors to achieve precise control over the number of receptors present on the cell surface. This approach addresses the need for a standardized method to validate the binding efficiency of molecular imaging probes. The team focused on modulating hemagglutinin tag expression in breast cancer cells to simulate various target concentrations. By varying the viral multiplicity of infection, they intended to create a predictable range of receptor densities. This work provides a framework for assessing how receptor availability influences the accumulation of targeted microbubbles. The researchers aimed to demonstrate that this controlled system yields reliable and reproducible data for diagnostic agent development.

Keywords:
molecular imagingmicrobubblestargeted deliverygene expression regulation

Frequently Asked Questions

The researchers propose that binding efficiency is directly proportional to the density of hemagglutinin tags on the cell surface. This mechanism allows for the predictable accumulation of microbubbles, as evidenced by the significant correlation between adenoviral multiplicity of infection and antibody binding levels.

The team utilized adenoviral vectors to deliver genes encoding the hemagglutinin tag under the control of a cytomegalovirus promoter. This tool enables precise regulation of receptor expression by adjusting the multiplicity of infection, which ranges from zero to one hundred.

A streptavidin bridge is necessary to link biotinylated anti-hemagglutinin antibodies to the biotin-coated surface of the microbubbles. This technical requirement ensures the stable conjugation of the targeting moiety to the contrast agent, facilitating specific binding to the induced receptors.

More Related Videos

A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents
08:02

A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents

Published on: July 16, 2020

Related Experiment Videos

Last Updated: May 31, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents
08:02

A High-Throughput Image-Guided Stereotactic Neuronavigation and Focused Ultrasound System for Blood-Brain Barrier Opening in Rodents

Published on: July 16, 2020

Main Methods:

The review approach involved constructing a model system using breast cancer cells to assess microbubble performance. Investigators utilized adenoviral vectors to induce the expression of hemagglutinin tags on the cell membrane. They varied the multiplicity of infection from zero to one hundred to achieve different receptor densities. A green fluorescent protein reporter served to monitor the success of gene transfer procedures. Researchers conjugated anti-hemagglutinin antibodies to biotinylated microbubbles via a streptavidin bridge for targeted delivery. They examined antibody binding and receptor levels through flow cytometry analysis. The team incubated these targeted microbubbles with infected cells to determine binding affinity. This methodology allowed for a systematic comparison between targeted and isotype control groups.

Main Results:

Key findings from the literature indicate that green fluorescent protein expression correlates strongly with the multiplicity of infection, yielding an r-squared value of 0.96. Increasing the viral dose resulted in a significant rise in anti-hemagglutinin antibody binding on the cell surface with p-values below 0.01. No significant differences appeared between cell groups exposed to anti-hemagglutinin antibodies at a multiplicity of infection of zero. The isotype control group showed no significant binding, confirming minimal nonspecific interactions with p-values exceeding 0.44. Similarly, cell groups incubated with isotype-targeted microbubbles displayed no significant binding regardless of the receptor density. Cells exposed to hemagglutinin-targeted microbubbles demonstrated increased binding levels proportional to the induced receptor expression. These targeted binding results achieved statistical significance with p-values below 0.02. The data confirm that the model effectively regulates receptor density to evaluate agent performance.

Conclusions:

The authors propose that their model system successfully establishes a predictable relationship between receptor density and microbubble binding. This approach confirms that targeted agents exhibit binding proportional to the available surface markers. The findings suggest that nonspecific interactions remain minimal when using isotype controls under these experimental conditions. Researchers can utilize this platform to standardize the evaluation of various molecular imaging probes in vitro. The data indicate that the viral vector method provides a robust tool for modulating target expression levels. This work highlights the utility of controlled receptor expression in refining ultrasound contrast agent development. The study demonstrates that binding efficiency correlates strongly with the density of induced hemagglutinin tags. These results offer a reliable framework for future investigations into targeted diagnostic imaging technologies.

The researchers employed flow cytometry to quantify both the expression of the green fluorescent protein reporter and the binding of anti-hemagglutinin antibodies. This data type provides a clear measurement of surface protein density and subsequent microbubble attachment across different experimental groups.

The study measured the correlation between the multiplicity of infection and green fluorescent protein expression, finding an r-squared value of 0.96. This measurement confirms that the viral delivery system effectively modulates target protein production in a dose-dependent manner.

The authors suggest that this model provides a standardized platform for evaluating the efficacy of novel targeted ultrasound contrast agents. They propose that this approach reduces variability in testing, allowing for more accurate comparisons between different imaging probe designs.